As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Pharmaceutical innovation is the energy to upgrade the industrial structure. The First Guangzhou Multinational Pharmaceutical R&D Summit, which is co-hosted by Guangzhou Service Center for Scholarly Exchange and Guangzhou Bioengineering Center, was successfully held at Guangzhou Doubletree Hotel on December 19, 2014. Dr. Chunlin Chen, Medicilon CEO, was invited to participate as one of the speakers and panelists.
During the summit, Dr. Chen discussed with the other five expert panelists on the topics, “New Models of Collaboration” and “How to develop between the innovative environment and Guangzhou pharmaceutical industry?” Beside, the panel discussion, Dr. Chen also gave a speech with the topic, “The New Model of Drug Development, IP-CRO-Local Pharmaceutical Companies or IP-CRO-VC’s collaboration.”
Relevant
news
marketing@medicilon.com
ABOUT
